ABSTRACT
The COVID-19 pandemic posed a major challenge in all areas of life, both for healthcare professionals and all patients treated in hospitals at the time, and especially COVID-positive patients who developed acute respiratory syndrome or pneumonia. These patients were respiratory dependent in intensive care units and during treatment they developed symptoms of acute coronary heart disease and acute myocardial infarction (AMI).1 The major challenges posed to nurses during a pandemic are numerous from psychological support to patients, patient’s families who did not have access to their loved ones, protective equipment, placing the patient in a pronation position, monitoring hemodynamic changes and that are just some of the tasks that nurses needed to respond to. We will attempt to demonstrate some of the challenges in health care that we face by presenting the case of patients with AMI during treatment in the intensive COVID unit. (English) [ABSTRACT FROM AUTHOR] Pandemija COVID-19 je pred nas stavila veliki izazov u svim područjima života, kako zdravstvenih radnika, tako i svih bolesnika koji su se u to vrijeme liječili u bolnicama, a naročito COVID pozitivnih bolesnika koji su razvili akutni respiracijski sindrom ili pneumoniju. Takvi bolesnici bili su ovisni o respiratoru u jedinicama intenzivnog liječenja te tijekom liječenja razvili simptome akutne koronarne bolesti i akutni infarkt miokardan (AIM).1 Veliki izazovi koji su postavljeni pred medicinske sestre tijekom pandemije su brojni od psihološke potpore, obitelji bolesnika koje nisu imale pristup svojim najbližima, zaštitne opreme, postavljanje bolesnika u pronacijski položaj, praćenje hemodinamskih promjena, a to su samo neki od zadataka na koje su sestre trebale odgovoriti. Prikazom slučaja bolesnika s AIM za vrijeme liječenja u COVID intenzivnoj jedinici pokušat ćemo prikazati neke od izazova u zdravstvenoj njezi. (Croatian) [ABSTRACT FROM AUTHOR] Copyright of Cardiologia Croatica is the property of Croatian Cardiac Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
ABSTRACT
BACKGROUND: The aim of this study was to examine the impact of education, coronavirus disease 2019 (COVID-19), and risk factors on the quality of life in patients with type 2 diabetes. METHODS: A prospective study was conducted in three phases: before education, after education, and in the period of pandemic coronavirus disease 2019 (COVID-19). The subjects were diabetics on oral therapy. To determine the quality of life index, a standardized Ferrans and Powers survey questionnaire was used. RESULTS: A total of 205 participants took part in the study, of which 111 (54.1%) were men and 94 (46%) women. Participants were enrolled in the study between January 2019 and September 2020. Glycated hemoglobin values were significantly higher before education compared to post-education and at the time of COVID-19 (Friedman test, p = 0.002), and body mass index was significantly lower after education compared to values before education (Friedman test, p = 0.008). The quality of life was significantly lower in all domains in the COVID-19 period (Friedman test, p < 0.001). CONCLUSIONS: A significant predictor of worse assessment of overall quality of life was male gender and rural place of residence. Disease duration of up to 5 years was a significant predictor of worse assessment in the psychological/spiritual domain, while being married was a predictor of better assessment of the quality of life in the family domain. The education of diabetics brought an increase in the health and quality of life while the coronavirus disease pandemic had negative consequences on the same parameters. We consider it necessary to systematically educate diabetics about the comorbidity of COVID-19.